Factor VIII 1:5

This test measures the activity of factor VIII, a protein that helps your blood form stable clots after an injury. The assay uses a diluted sample to keep results within the analytical range and improves accuracy when activity is near normal.

It is performed on a blood sample treated to prevent clotting until the laboratory evaluates how well factor VIII works within the clotting cascade.

Doctors use this test to investigate easy bruising, prolonged bleeding, heavy menstrual bleeding, or bleeding after procedures. It helps diagnose hemophilia A and can detect acquired problems with factor VIII that may develop later in life. It is also used to monitor response to treatments such as desmopressin or factor replacement products.

Results can inform decisions before surgery or dental work, guide therapy during bleeding episodes, and help assess recovery after a flare of illness. Elevated activity can occur with inflammation, pregnancy, or hormone therapy and may be associated with clotting risk in certain situations. Your care team interprets the result together with your history, exam, and other labs.

If your activity is lower than expected, your clinician may consider inherited hemophilia A, a decreased level due to another condition, or the presence of an inhibitor that blocks factor VIII. Additional tests, such as mixing studies or chromogenic assays, may be performed to clarify the cause. If you are on treatment, results can show whether your therapy is providing enough factor activity.

If your activity is higher than expected, it can reflect temporary changes from stress, illness, pregnancy, or medicines. Your clinician may repeat testing when you are well or adjust timing to avoid short-term influences. Regardless of the direction of change, follow-up focuses on your symptoms and overall risk, and may include repeat testing, evaluation for inhibitors, or coordination with a hematology specialist when needed.